Target intelligence / Profile preview

General cellular metabolic and signaling pathways

Molecular classification
Other
01

Overview

General cellular metabolic and signaling pathways refers to the integrated network of chemical reactions and molecular interactions that sustain life within a cell. Metabolic pathways, such as glycolysis and the tricarboxylic acid cycle, are responsible for converting nutrients into energy and biosynthetic precursors (National Center for Biotechnology Information [NCBI], 2023). Signaling pathways, including the G protein-coupled receptor (GPCR) and receptor tyrosine kinase (RTK) systems, allow cells to perceive and respond to their environment by regulating processes like proliferation, differentiation, and apoptosis (Nature Education, 2014). While these pathways contain numerous individual therapeutic targets, the term itself is a broad biological classification rather than a specific molecular entity. Dysregulation across these pathways is a hallmark of various pathologies, including cancer, metabolic syndrome, and neurodegeneration (Hanahan & Weinberg, Cell, 2011). Consequently, drug development focuses on specific enzymes or receptors within these networks rather than the pathways in their entirety. Because this entry represents a collection of processes rather than a single protein or receptor, it does not possess a singular mechanism of action or a specific set of interacting drugs. Understanding these pathways is fundamental to pharmacology, as most drugs aim to modulate specific nodes within these complex systems to restore homeostasis (StatPearls, 2023).

Other names
Cellular metabolismSignal transductionMetabolic networksIntracellular signaling
02

Mechanism of action

Not applicable. This entry describes a broad set of biological processes rather than a specific molecular target that can be modulated by a single drug mechanism.

03

Biological functions

MetabolismSignal transductionCell proliferationApoptosisHomeostasis
04

Disease associations

CancerDiabetes mellitusNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Systemic toxicityLack of therapeutic indexWidespread off-target effects

Beyond the preview

Go deeper on General cellular metabolic and signaling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General cellular metabolic and signaling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call